Skip to main content
Erschienen in: Drugs 7/2009

01.05.2009 | Review Article

Cranberry and Urinary Tract Infections

verfasst von: Dr David R.P. Guay

Erschienen in: Drugs | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Abstract

Urinary tract infection (UTI) refers to the presence of clinical signs and symptoms arising from the genitourinary tract plus the presence of one or more micro-organisms in the urine exceeding a threshold value for significance (ranges from 102 to 103 colony-forming units/mL). Infections are localized to the bladder (cystitis), renal parenchyma (pyelonephritis) or prostate (acute or chronic bacterial prostatitis). Single UTI episodes are very common, especially in adult women where there is a 50-fold predominance compared with adult men. In addition, recurrent UTIs are also common, occurring in up to one-third of women after first-episode UTIs. Recurrences requiring intervention are usually defined as two or more episodes over 6 months or three or more episodes over 1 year (this definition applies only to young women with acute uncomplicated UTIs).
A cornerstone of prevention of UTI recurrence has been the use of low-dose once-daily or post-coital antimicrobials; however, much interest has surrounded non-antimicrobial-based approaches undergoing investigation such as use of probiotics, vaccines, oligosaccharide inhibitors of bacterial adherence and colonization, and bacterial interference with immunoreactive extracts of Escherichia coli. Local (intravaginal) estrogen therapy has had mixed results to date.
Cranberry products in a variety of formulations have also undergone extensive evaluation over several decades in the management of UTIs. At present, there is no evidence that cranberry can be used to treat UTIs. Hence, the focus has been on its use as a preventative strategy. Cranberry has been effective in vitro and in vivo in animals for the prevention of UTI. Cranberry appears to work by inhibiting the adhesion of type I and P-fimbriated uro-pathogens (e.g. uropathogenic E. coli) to the uroepithelium, thus impairing colonization and subsequent infection. The isolation of the component(s) of cranberry with this activity has been a daunting task, considering the hundreds of compounds found in the fruit and its juice derivatives. Reasonable evidence suggests that the anthocyanidin/proanthocyanidin moieties are potent antiadhesion compounds. However, problems still exist with standardization of cranberry products, which makes it extremely difficult to compare products or extrapolate results. Unfortunately, most clinical trials have had design deficiencies and none have evaluated specific key cranberry-derived compounds considered likely to be active moieties (e.g. proantho-cyanidins). In general, the preventive efficacy of cranberry has been variable and modest at best. Meta-analyses have established that recurrence rates over 1 year are reduced approximately 35% in young to middle-aged women. The efficacy of cranberry in other groups (i.e. elderly, paediatric patients, those with neurogenic bladder, those with chronic indwelling urinary catheters) is questionable. Withdrawal rates have been quite high (up to 55%), suggesting that these products may not be acceptable over long periods. Adverse events include gastrointestinal intolerance, weight gain (due to the excessive calorie load) and drug-cranberry interactions (due to the inhibitory effect of flavo-noids on cytochrome P450-mediated drug metabolism). The findings of the Cochrane Collaboration support the potential use of cranberry products in the prophylaxis of recurrent UTIs in young and middle-aged women. However, in light of the heterogeneity of clinical study designs and the lack of consensus regarding the dosage regimen and formulation to use, cranberry products cannot be recommended for the prophylaxis of recurrent UTIs at this time.
Literatur
1.
Zurück zum Zitat Guay DRP. Contemporary management of uncomplicated urinary tract infections. Drugs 2008; 68: 1169–205PubMedCrossRef Guay DRP. Contemporary management of uncomplicated urinary tract infections. Drugs 2008; 68: 1169–205PubMedCrossRef
2.
Zurück zum Zitat Stapleton A. Novel approaches to prevention of urinary tract infections. Infect Dis Clin North Am 2003; 17: 457–71PubMedCrossRef Stapleton A. Novel approaches to prevention of urinary tract infections. Infect Dis Clin North Am 2003; 17: 457–71PubMedCrossRef
3.
Zurück zum Zitat Miller JL, Krieger JN. Urinary tract infections: cranberry juice, underwear, and probiotics in the 21st century. Urol Clin North Am 2002; 29: 695–9PubMedCrossRef Miller JL, Krieger JN. Urinary tract infections: cranberry juice, underwear, and probiotics in the 21st century. Urol Clin North Am 2002; 29: 695–9PubMedCrossRef
4.
Zurück zum Zitat Ruel G, Couillard C. Evidence of the cardioprotective potential of fruits: the case of cranberries. Mol Nutr Food Res 2007; 51: 692–701PubMedCrossRef Ruel G, Couillard C. Evidence of the cardioprotective potential of fruits: the case of cranberries. Mol Nutr Food Res 2007; 51: 692–701PubMedCrossRef
5.
Zurück zum Zitat Neto CC. Cranberry and blueberry: evidence for protective effects against cancer and vascular diseases. Mol Nutr Food Res 2007; 51: 652–64PubMedCrossRef Neto CC. Cranberry and blueberry: evidence for protective effects against cancer and vascular diseases. Mol Nutr Food Res 2007; 51: 652–64PubMedCrossRef
6.
Zurück zum Zitat Weiss EI, Lev-Dor R, Sharon N, et al. Inhibitory effect of a high-molecular-weight constituent of cranberry on adhesion of oral bacteria. Crit Rev Food Sci Nutr 2002; 42 (Suppl.): 285–92PubMedCrossRef Weiss EI, Lev-Dor R, Sharon N, et al. Inhibitory effect of a high-molecular-weight constituent of cranberry on adhesion of oral bacteria. Crit Rev Food Sci Nutr 2002; 42 (Suppl.): 285–92PubMedCrossRef
7.
Zurück zum Zitat Steinberg D, Feldman M, Ofek I, et al. Cranberry high molecular weight constituents promote Streptococcus sobrinus desorption from artificial biofilm. Int J Anti-microb Agents 2005; 25: 247–51CrossRef Steinberg D, Feldman M, Ofek I, et al. Cranberry high molecular weight constituents promote Streptococcus sobrinus desorption from artificial biofilm. Int J Anti-microb Agents 2005; 25: 247–51CrossRef
8.
Zurück zum Zitat Duarte S, Gregoire S, Singh AP, et al. Inhibitory effects of cranberry polyphenols on formation and acidogenicity of Streptococcus mutans biofilms. FEMS Microbiol Lett 2006; 257: 50–56PubMedCrossRef Duarte S, Gregoire S, Singh AP, et al. Inhibitory effects of cranberry polyphenols on formation and acidogenicity of Streptococcus mutans biofilms. FEMS Microbiol Lett 2006; 257: 50–56PubMedCrossRef
9.
Zurück zum Zitat Weiss EI, Kozlovsky A, Steinberg D, et al. A high molecular mass cranberry constituent reduces mutans streptococci level in saliva and inhibits in vitro adhesion to hydroxyapatite. FEMS Microbiol Lett 2004; 232: 89–92PubMedCrossRef Weiss EI, Kozlovsky A, Steinberg D, et al. A high molecular mass cranberry constituent reduces mutans streptococci level in saliva and inhibits in vitro adhesion to hydroxyapatite. FEMS Microbiol Lett 2004; 232: 89–92PubMedCrossRef
10.
Zurück zum Zitat Vattem DA, Ghaedian R, Shetty K. Enhancing health benefits of berries through phenolic antioxidant enrichment: focus on cranberry. Asia Pac J Clin Nutr 2005; 14: 120–30PubMed Vattem DA, Ghaedian R, Shetty K. Enhancing health benefits of berries through phenolic antioxidant enrichment: focus on cranberry. Asia Pac J Clin Nutr 2005; 14: 120–30PubMed
11.
Zurück zum Zitat Yamanaka A, Kouchi T, Kasai K, et al. Inhibitory effect of cranberry polyphenol on biofilm formation and cysteine proteases of Porphyromonas gingivalis. J Periodont Res 2007; 42: 589–92PubMedCrossRef Yamanaka A, Kouchi T, Kasai K, et al. Inhibitory effect of cranberry polyphenol on biofilm formation and cysteine proteases of Porphyromonas gingivalis. J Periodont Res 2007; 42: 589–92PubMedCrossRef
12.
Zurück zum Zitat Labrecque J, Bodet C, Chandad F, et al. Effects of a high-molecular-weight cranberry fraction on growth, biofilm formation and adherence of Porphyromonas gingivalis. J Antimicrob Chemother 2006; 58: 439–43PubMedCrossRef Labrecque J, Bodet C, Chandad F, et al. Effects of a high-molecular-weight cranberry fraction on growth, biofilm formation and adherence of Porphyromonas gingivalis. J Antimicrob Chemother 2006; 58: 439–43PubMedCrossRef
13.
Zurück zum Zitat Bodet C, Piche M, Chandad F, et al. Inhibition of period-ontopathogen-derived proteolytic enzymes by a high-molecular-weight fraction isolated from cranberry. J Antimicrob Chemother 2006; 57: 685–90PubMedCrossRef Bodet C, Piche M, Chandad F, et al. Inhibition of period-ontopathogen-derived proteolytic enzymes by a high-molecular-weight fraction isolated from cranberry. J Antimicrob Chemother 2006; 57: 685–90PubMedCrossRef
14.
Zurück zum Zitat Lipson SM, Sethi L, Cohen P, et al. Antiviral effects on bacteriophages and rotavirus by cranberry juice. Phytomedicine 2007; 14: 23–30PubMedCrossRef Lipson SM, Sethi L, Cohen P, et al. Antiviral effects on bacteriophages and rotavirus by cranberry juice. Phytomedicine 2007; 14: 23–30PubMedCrossRef
15.
Zurück zum Zitat Weiss EI, Houri-Haddad Y, Greenbaum E, et al. Cranberry juice constituents affect influenza virus adhesion and infectivity. Antiviral Res 2005; 66: 9–12PubMedCrossRef Weiss EI, Houri-Haddad Y, Greenbaum E, et al. Cranberry juice constituents affect influenza virus adhesion and infectivity. Antiviral Res 2005; 66: 9–12PubMedCrossRef
16.
Zurück zum Zitat Lipson SM, Cohen P, Zhou J, et al. Cranberry cocktail juice, cranberry concentrates, and proanthocyanidins reduce reovirus infectivity titers in African green monkey kidney epithelial cell cultures. Mol Nutr Food Res 2007; 51: 752–8PubMedCrossRef Lipson SM, Cohen P, Zhou J, et al. Cranberry cocktail juice, cranberry concentrates, and proanthocyanidins reduce reovirus infectivity titers in African green monkey kidney epithelial cell cultures. Mol Nutr Food Res 2007; 51: 752–8PubMedCrossRef
17.
Zurück zum Zitat Ofek I, Goldhar J, Sharon N. Anti-Escherichia coli adhesion activity of cranberry and blueberry juices. Adv Exp Med Biol 1996; 408: 179–83PubMedCrossRef Ofek I, Goldhar J, Sharon N. Anti-Escherichia coli adhesion activity of cranberry and blueberry juices. Adv Exp Med Biol 1996; 408: 179–83PubMedCrossRef
18.
Zurück zum Zitat Fanos V, Atzei A, Zaffanello M, et al. Cranberry and prevention of urinary tract infections in children. J Chemother 2006; 18 Spec no. 3: 21–4 Fanos V, Atzei A, Zaffanello M, et al. Cranberry and prevention of urinary tract infections in children. J Chemother 2006; 18 Spec no. 3: 21–4
19.
Zurück zum Zitat Raz R, Chazan B, Dan M. Cranberry juice and urinary tract infection. Clin Infect Dis 2004; 38: 1413–9PubMedCrossRef Raz R, Chazan B, Dan M. Cranberry juice and urinary tract infection. Clin Infect Dis 2004; 38: 1413–9PubMedCrossRef
20.
Zurück zum Zitat Turner A, Chen S-N, Joike MK, et al. Inhibition of uro-pathogenic Escherichia coli by cranberry juice: a new antiadherence assay. J Agric Food Chem 2005; 53: 8940–7PubMedCrossRef Turner A, Chen S-N, Joike MK, et al. Inhibition of uro-pathogenic Escherichia coli by cranberry juice: a new antiadherence assay. J Agric Food Chem 2005; 53: 8940–7PubMedCrossRef
21.
Zurück zum Zitat Jensen HD, Krogfelt KA, Cornett C, et al. Hydrophilic carboxylic acids and iridoid glycosides in the juice of American and European cranberries (Vaccinium macro-carpon and V. oxycoccus), lingonberries (V. vitis-idaea), and blueberries (V. myrtillus). J Agric Food Chem 2002; 50: 6871–974PubMedCrossRef Jensen HD, Krogfelt KA, Cornett C, et al. Hydrophilic carboxylic acids and iridoid glycosides in the juice of American and European cranberries (Vaccinium macro-carpon and V. oxycoccus), lingonberries (V. vitis-idaea), and blueberries (V. myrtillus). J Agric Food Chem 2002; 50: 6871–974PubMedCrossRef
22.
Zurück zum Zitat Zhang K, Zuo Y. GC-MS determination of flavonoids and phenolic and benzoic acids in human plasma after consumption of cranberry juices. J Agric Food Chem 2004; 52: 222–7PubMedCrossRef Zhang K, Zuo Y. GC-MS determination of flavonoids and phenolic and benzoic acids in human plasma after consumption of cranberry juices. J Agric Food Chem 2004; 52: 222–7PubMedCrossRef
23.
Zurück zum Zitat Duthie GB, Kyle JAM, Jenkinson AMcE, et al. Increased salicylate concentrations in urine of human volunteers after consumption of cranberry juice. J Agric Food Chem 2005; 53: 2897–900PubMedCrossRef Duthie GB, Kyle JAM, Jenkinson AMcE, et al. Increased salicylate concentrations in urine of human volunteers after consumption of cranberry juice. J Agric Food Chem 2005; 53: 2897–900PubMedCrossRef
24.
Zurück zum Zitat Vvedenskaya IO, Rosen RT, Guido JE, et al. Characterization of flavonols in cranberry (Vaccinium macrocarpon) powder. J Agric Food Chem 2004; 52: 188–95PubMedCrossRef Vvedenskaya IO, Rosen RT, Guido JE, et al. Characterization of flavonols in cranberry (Vaccinium macrocarpon) powder. J Agric Food Chem 2004; 52: 188–95PubMedCrossRef
25.
Zurück zum Zitat Hakkinen SH, Karenlampi SO, Heinonen IM, et al. Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries. J Agric Food Chem 1999; 47: 2274–9PubMedCrossRef Hakkinen SH, Karenlampi SO, Heinonen IM, et al. Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries. J Agric Food Chem 1999; 47: 2274–9PubMedCrossRef
26.
Zurück zum Zitat Ohnishi R, Ito H, Kasajima N, et al. Urinary excretion of anthocyanins in humans after cranberry juice ingestion. Biosci Biotechnol Biochem 2006; 70: 1681–7PubMedCrossRef Ohnishi R, Ito H, Kasajima N, et al. Urinary excretion of anthocyanins in humans after cranberry juice ingestion. Biosci Biotechnol Biochem 2006; 70: 1681–7PubMedCrossRef
27.
Zurück zum Zitat Foo LY, Lu Y, Howell AB, et al. The structure of cranberry proanthocyanidins which inhibit adherence of uropathogenic P-fimbriated Escherichia coli in vitro. Phytochemistry 2000; 54: 173–81PubMedCrossRef Foo LY, Lu Y, Howell AB, et al. The structure of cranberry proanthocyanidins which inhibit adherence of uropathogenic P-fimbriated Escherichia coli in vitro. Phytochemistry 2000; 54: 173–81PubMedCrossRef
28.
Zurück zum Zitat Howell AB, Reed JD, Krueger CG, et al. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry 2005; 66: 2281–91PubMedCrossRef Howell AB, Reed JD, Krueger CG, et al. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry 2005; 66: 2281–91PubMedCrossRef
29.
Zurück zum Zitat Gupta K, Chou MY, Howell A, et al. Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells. J Urol 2007; 177: 2357–60PubMedCrossRef Gupta K, Chou MY, Howell A, et al. Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells. J Urol 2007; 177: 2357–60PubMedCrossRef
30.
Zurück zum Zitat Sobota AE. Inhibition of bacterial adherence by cranberry juice: potential use for the treatment of urinary tract infections. J Urol 1984; 131: 1013–6PubMed Sobota AE. Inhibition of bacterial adherence by cranberry juice: potential use for the treatment of urinary tract infections. J Urol 1984; 131: 1013–6PubMed
31.
Zurück zum Zitat Ahuja S, Kaack B, Roberts J. Loss of fimbrial adhesion with the addition of Vaccinium macrocarpon to the growth medium of P-fimbriated Escherichia coli. J Urol 1998; 159: 559–62PubMedCrossRef Ahuja S, Kaack B, Roberts J. Loss of fimbrial adhesion with the addition of Vaccinium macrocarpon to the growth medium of P-fimbriated Escherichia coli. J Urol 1998; 159: 559–62PubMedCrossRef
32.
Zurück zum Zitat Valentova K, Stejskal D, Bednar P, et al. Biosafety, anti-oxidant status, and metabolites in urine after consumption of dried cranberry juice in healthy women: a pilot double-blind placebo-controlled trial. J Agric Food Chem 2007; 55: 3217–24PubMedCrossRef Valentova K, Stejskal D, Bednar P, et al. Biosafety, anti-oxidant status, and metabolites in urine after consumption of dried cranberry juice in healthy women: a pilot double-blind placebo-controlled trial. J Agric Food Chem 2007; 55: 3217–24PubMedCrossRef
33.
Zurück zum Zitat Lee Y-L, Owens J, Thrupp L, et al. Does cranberry juice have any antibacterial activity? [letter]. JAMA 2000; 283: 1691PubMedCrossRef Lee Y-L, Owens J, Thrupp L, et al. Does cranberry juice have any antibacterial activity? [letter]. JAMA 2000; 283: 1691PubMedCrossRef
34.
Zurück zum Zitat Allison DG, Cronin MA, Hawker J, et al. Influence of cranberry juice on attachment of Escherichia coli to glass. J Basic Microbiol 2000; 40: 3–6PubMedCrossRef Allison DG, Cronin MA, Hawker J, et al. Influence of cranberry juice on attachment of Escherichia coli to glass. J Basic Microbiol 2000; 40: 3–6PubMedCrossRef
35.
Zurück zum Zitat Cavanagh HMA, Hipwell M, Wilkinson JM. Antibacterial activity of berry fruits used for culinary purposes. J Med Food 2003; 6: 57–61PubMedCrossRef Cavanagh HMA, Hipwell M, Wilkinson JM. Antibacterial activity of berry fruits used for culinary purposes. J Med Food 2003; 6: 57–61PubMedCrossRef
36.
Zurück zum Zitat Leitao DPS, Polizello ACM, Ito IY, et al. Antibacterial screening of anthocyanic and proanthocyanic fractions from cranberry juice. J Med Food 2005; 8: 36–40PubMedCrossRef Leitao DPS, Polizello ACM, Ito IY, et al. Antibacterial screening of anthocyanic and proanthocyanic fractions from cranberry juice. J Med Food 2005; 8: 36–40PubMedCrossRef
37.
Zurück zum Zitat Zafriri D, Ofek I, Adar R, et al. Inhibitory activity of cranberry juice on adherence of type 1 and type P fim-briated Escherichia coli to eukaryotic cells. Antimicrob Agents Chemother 1989; 33: 92–8PubMedCrossRef Zafriri D, Ofek I, Adar R, et al. Inhibitory activity of cranberry juice on adherence of type 1 and type P fim-briated Escherichia coli to eukaryotic cells. Antimicrob Agents Chemother 1989; 33: 92–8PubMedCrossRef
38.
Zurück zum Zitat Schmidt DR, Sobota AE. An examination of the anti-adherence activity of cranberry juice on urinary and nonurinary bacterial isolates. Microbios 1988; 55: 173–81PubMed Schmidt DR, Sobota AE. An examination of the anti-adherence activity of cranberry juice on urinary and nonurinary bacterial isolates. Microbios 1988; 55: 173–81PubMed
39.
Zurück zum Zitat Johnson-White B, Buquo L, Zeinali M, et al. Prevention of nonspecific bacterial cell adhesion in immunoassays by use of cranberry juice. Anal Chem 2006; 78: 853–7PubMedCrossRef Johnson-White B, Buquo L, Zeinali M, et al. Prevention of nonspecific bacterial cell adhesion in immunoassays by use of cranberry juice. Anal Chem 2006; 78: 853–7PubMedCrossRef
40.
Zurück zum Zitat Eydelnant IA, Tufenkji N. Cranberry derived proanthocyanidins reduce bacterial adhesion to selected biomate-rials. Langmuir 2008; 24: 10273–81PubMedCrossRef Eydelnant IA, Tufenkji N. Cranberry derived proanthocyanidins reduce bacterial adhesion to selected biomate-rials. Langmuir 2008; 24: 10273–81PubMedCrossRef
41.
Zurück zum Zitat Koo H, Nino de Guzman P, Schobel BD, et al. Influence of cranberry juice on glucan-mediated processes involved in Streptococcus mutans biofilm development. Caries Res 2006; 40: 20–7PubMedCrossRef Koo H, Nino de Guzman P, Schobel BD, et al. Influence of cranberry juice on glucan-mediated processes involved in Streptococcus mutans biofilm development. Caries Res 2006; 40: 20–7PubMedCrossRef
42.
Zurück zum Zitat Dearing MD, Appel HM, Schultz JC. Why do cranberries reduce incidence of urinary tract infections? [letter]. J Ethnopharmacol 2002; 80: 211PubMedCrossRef Dearing MD, Appel HM, Schultz JC. Why do cranberries reduce incidence of urinary tract infections? [letter]. J Ethnopharmacol 2002; 80: 211PubMedCrossRef
43.
Zurück zum Zitat Howell AB, Foxman B. Cranberry juice and adhesion of antibiotic-resistant uropathogens [letter]. JAMA 2002; 287: 3082–3PubMedCrossRef Howell AB, Foxman B. Cranberry juice and adhesion of antibiotic-resistant uropathogens [letter]. JAMA 2002; 287: 3082–3PubMedCrossRef
44.
Zurück zum Zitat Foo LY, Lu Y, Howell AB, et al. A-type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic Escherichia coli. J Natl Prod 2000; 63: 1225–8CrossRef Foo LY, Lu Y, Howell AB, et al. A-type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic Escherichia coli. J Natl Prod 2000; 63: 1225–8CrossRef
45.
Zurück zum Zitat Di Martino P, Agniel R, Gaillard JL, et al. Effects of cranberry juice on uropathogenic Escherichia coli in vitro biofilm formation. J Chemother 2005; 17: 563–5PubMed Di Martino P, Agniel R, Gaillard JL, et al. Effects of cranberry juice on uropathogenic Escherichia coli in vitro biofilm formation. J Chemother 2005; 17: 563–5PubMed
46.
Zurück zum Zitat Reid G, Hsiehl J, Potter P, et al. Cranberry juice consumption may reduce biofilms on uroepithelial cells: pilot study in spinal cord injured patients. Spinal Cord 2001; 39: 26–30PubMedCrossRef Reid G, Hsiehl J, Potter P, et al. Cranberry juice consumption may reduce biofilms on uroepithelial cells: pilot study in spinal cord injured patients. Spinal Cord 2001; 39: 26–30PubMedCrossRef
47.
Zurück zum Zitat Morris NS, Strickler DJ. Does drinking cranberry juice produce urine inhibitory to the development of crystalline, catheter-blocking Proteus mirabilis biofilms? BJU Int 2001; 88: 192–7PubMedCrossRef Morris NS, Strickler DJ. Does drinking cranberry juice produce urine inhibitory to the development of crystalline, catheter-blocking Proteus mirabilis biofilms? BJU Int 2001; 88: 192–7PubMedCrossRef
48.
49.
Zurück zum Zitat Bodel PT, Cotran R, Kass EH. Cranberry juice and the antibacterial action of hippuric acid. J Lab Clin Med 1959; 54: 881–8PubMed Bodel PT, Cotran R, Kass EH. Cranberry juice and the antibacterial action of hippuric acid. J Lab Clin Med 1959; 54: 881–8PubMed
50.
Zurück zum Zitat Fellers CR, Redmon BC, Parrott EM. Effect of cranberries on urinary acidity and blood alkali reserve. J Nutrition 1933; 6: 455–63 Fellers CR, Redmon BC, Parrott EM. Effect of cranberries on urinary acidity and blood alkali reserve. J Nutrition 1933; 6: 455–63
51.
Zurück zum Zitat Blatherwick NR, Long ML. Studies of urinary acidity. II: the increased acidity produced by eating prunes and cranberries. J Biol Chem 1923; 57: 815–8 Blatherwick NR, Long ML. Studies of urinary acidity. II: the increased acidity produced by eating prunes and cranberries. J Biol Chem 1923; 57: 815–8
52.
Zurück zum Zitat Kahn HD, Panariello VA, Saeli J, et al. Effect of cranberry juice on urine. J Am Diet Assoc 1967; 51: 251–4PubMed Kahn HD, Panariello VA, Saeli J, et al. Effect of cranberry juice on urine. J Am Diet Assoc 1967; 51: 251–4PubMed
53.
Zurück zum Zitat Nahata HC, Cummins BA, McLeod DC, et al. Predictability of methenamine efficacy based on type of urinary pathogen and pH. J Am Geriatr Soc 1981; 29: 236–9PubMed Nahata HC, Cummins BA, McLeod DC, et al. Predictability of methenamine efficacy based on type of urinary pathogen and pH. J Am Geriatr Soc 1981; 29: 236–9PubMed
54.
Zurück zum Zitat Jackson B, Hicks LE. Effect of cranberry juice on urinary pH in older adults. Home Health Nurse 1997; 15: 198–202 Jackson B, Hicks LE. Effect of cranberry juice on urinary pH in older adults. Home Health Nurse 1997; 15: 198–202
55.
Zurück zum Zitat Blatherwick NR. The specific role of foods in relation to the composition of the urine. Arch Intern Med 1914; 14: 409–50CrossRef Blatherwick NR. The specific role of foods in relation to the composition of the urine. Arch Intern Med 1914; 14: 409–50CrossRef
56.
Zurück zum Zitat Habash MB, van der Mei HC, Busscher HJ, et al. The effect of water, ascorbic acid, and cranberry derived supplementation on human urine and uropathogen adhesion to silicone rubber. Can J Microbiol 1999; 45: 691–4PubMedCrossRef Habash MB, van der Mei HC, Busscher HJ, et al. The effect of water, ascorbic acid, and cranberry derived supplementation on human urine and uropathogen adhesion to silicone rubber. Can J Microbiol 1999; 45: 691–4PubMedCrossRef
57.
Zurück zum Zitat Lavigne J-P, Bourg G, Combescure C, et al. In-vitro and in-vivo evidence of dose-dependent decrease of uropathogenic Escherichia coli virulence after consumption of commercial Vaccinium macrocarpon (cranberry) capsules. Clin Microbiol Infect 2008; 14: 350–5PubMedCrossRef Lavigne J-P, Bourg G, Combescure C, et al. In-vitro and in-vivo evidence of dose-dependent decrease of uropathogenic Escherichia coli virulence after consumption of commercial Vaccinium macrocarpon (cranberry) capsules. Clin Microbiol Infect 2008; 14: 350–5PubMedCrossRef
58.
Zurück zum Zitat Han CH, Kim SH, Kang SH, et al. Protective effects of cranberries on infection-induced oxidative renal damage in a rabbit model of vesico-ureteric reflux. BJU Int 2007; 100: 1172–5PubMed Han CH, Kim SH, Kang SH, et al. Protective effects of cranberries on infection-induced oxidative renal damage in a rabbit model of vesico-ureteric reflux. BJU Int 2007; 100: 1172–5PubMed
59.
Zurück zum Zitat Tong H, Heong S, Chang S. Effect of ingesting cranberry juice on bacterial growth in urine. Am J Health-Syst Pharm 2006; 63: 1417–9PubMedCrossRef Tong H, Heong S, Chang S. Effect of ingesting cranberry juice on bacterial growth in urine. Am J Health-Syst Pharm 2006; 63: 1417–9PubMedCrossRef
60.
Zurück zum Zitat Greenberg JA, Newmann SJ, Howell AB. Consumption of sweetened dried cranberries versus unsweetened raisins for inhibition of uropathogenic Escherichia coli adhesion in human urine: a pilot study. J Altern Compl Med 2005; 11: 875–8CrossRef Greenberg JA, Newmann SJ, Howell AB. Consumption of sweetened dried cranberries versus unsweetened raisins for inhibition of uropathogenic Escherichia coli adhesion in human urine: a pilot study. J Altern Compl Med 2005; 11: 875–8CrossRef
61.
Zurück zum Zitat Di Martino P, Agniel R, David K, et al. Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: a double-blind randomized placebo-controlled cross-over trial. World J Urol 2006; 24: 21–7PubMedCrossRef Di Martino P, Agniel R, David K, et al. Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: a double-blind randomized placebo-controlled cross-over trial. World J Urol 2006; 24: 21–7PubMedCrossRef
62.
Zurück zum Zitat Saltzman JR, Kemp JA, Golner BB, et al. Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein bound vitamin B12 absorption. J Am Coll Nutrition 1994; 13: 584–91 Saltzman JR, Kemp JA, Golner BB, et al. Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein bound vitamin B12 absorption. J Am Coll Nutrition 1994; 13: 584–91
63.
Zurück zum Zitat Rhee KY, Charles M. Antimicrobial mechanisms of cranberry juice [letter]. Clin Infect Dis 2004; 39: 877PubMedCrossRef Rhee KY, Charles M. Antimicrobial mechanisms of cranberry juice [letter]. Clin Infect Dis 2004; 39: 877PubMedCrossRef
64.
Zurück zum Zitat Ofek I, Mirelman D, Sharon N. Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors. Nature 1977; 265: 623–5PubMedCrossRef Ofek I, Mirelman D, Sharon N. Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors. Nature 1977; 265: 623–5PubMedCrossRef
65.
Zurück zum Zitat Aronson M, Medalia O, Schori L, et al. Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl α-D-mannopyranoside. J Infect Dis 1979; 139: 329–32PubMedCrossRef Aronson M, Medalia O, Schori L, et al. Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl α-D-mannopyranoside. J Infect Dis 1979; 139: 329–32PubMedCrossRef
66.
Zurück zum Zitat Liu Y, Black MA, Caron L, et al. Role of cranberry juice on molecular-scale surface characteristics and adhesion behavior of Escherichia coli. Biotechnol Bioengineer 2006; 93: 297–305CrossRef Liu Y, Black MA, Caron L, et al. Role of cranberry juice on molecular-scale surface characteristics and adhesion behavior of Escherichia coli. Biotechnol Bioengineer 2006; 93: 297–305CrossRef
67.
Zurück zum Zitat Liu Y, Gallardo-Moreno AM, Pinzon-Arango PA, et al. Cranberry changes the physicochemical surface properties of E. coli and adhesion with uroepithelial cells. Coll Surf B: Biointerfaces 2008; 65: 35–42CrossRef Liu Y, Gallardo-Moreno AM, Pinzon-Arango PA, et al. Cranberry changes the physicochemical surface properties of E. coli and adhesion with uroepithelial cells. Coll Surf B: Biointerfaces 2008; 65: 35–42CrossRef
68.
Zurück zum Zitat Gibson L, Pike L, Kilbourn JP. Effectiveness of cranberry juice in preventing urinary tract infections in long-term care facility patients. J Naturopath Med 1991; 2: 45–7 Gibson L, Pike L, Kilbourn JP. Effectiveness of cranberry juice in preventing urinary tract infections in long-term care facility patients. J Naturopath Med 1991; 2: 45–7
69.
Zurück zum Zitat Moen DV. Observations on the effectiveness of cranberry juice in urinary infections. Wisc Med J 1962; 61: 282–3 Moen DV. Observations on the effectiveness of cranberry juice in urinary infections. Wisc Med J 1962; 61: 282–3
70.
Zurück zum Zitat Nowack R, Schmitt W. Cranberry juice for prophylaxis of urinary tract infections-conclusions from clinical experience and research. Phytomedicine 2008; 15: 653–67CrossRef Nowack R, Schmitt W. Cranberry juice for prophylaxis of urinary tract infections-conclusions from clinical experience and research. Phytomedicine 2008; 15: 653–67CrossRef
71.
Zurück zum Zitat Walker EB, Barney DP, Mickelson JN, et al. Cranberry concentrate: UTI prophylaxis [letter]. J Fam Prac 1997; 45: 167–8 Walker EB, Barney DP, Mickelson JN, et al. Cranberry concentrate: UTI prophylaxis [letter]. J Fam Prac 1997; 45: 167–8
72.
Zurück zum Zitat Kontiokari T, Sundqvist K, Nuutinen M, et al. Randomized trial of cranberry-lingonberry juice and lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 2001; 322: 1571–3PubMedCrossRef Kontiokari T, Sundqvist K, Nuutinen M, et al. Randomized trial of cranberry-lingonberry juice and lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 2001; 322: 1571–3PubMedCrossRef
73.
Zurück zum Zitat Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol 2002; 9: 1558–62PubMed Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol 2002; 9: 1558–62PubMed
74.
Zurück zum Zitat Bailey DT, Dalton C, Daugherty FJ, et al. Can a concentrated cranberry extract prevent recurrent urinary tract infections in women? A pilot study. Phytomedicine 2007; 14: 237–41PubMedCrossRef Bailey DT, Dalton C, Daugherty FJ, et al. Can a concentrated cranberry extract prevent recurrent urinary tract infections in women? A pilot study. Phytomedicine 2007; 14: 237–41PubMedCrossRef
75.
Zurück zum Zitat McGuinness SD, Krone R, Metz LM. A double-blind, randomized, placebo-controlled trial of cranberry supplements in multiple sclerosis. J Neurosci Nurs 2002; 34: 4–7CrossRef McGuinness SD, Krone R, Metz LM. A double-blind, randomized, placebo-controlled trial of cranberry supplements in multiple sclerosis. J Neurosci Nurs 2002; 34: 4–7CrossRef
76.
Zurück zum Zitat Waites KB, Canupp KC, Armstrong S, et al. Effect of cranberry extract on bacteriuria and pyuria in persons with neurogenic bladder secondary to spinal cord injury. J Spinal Cord Med 2004; 27: 35–40PubMed Waites KB, Canupp KC, Armstrong S, et al. Effect of cranberry extract on bacteriuria and pyuria in persons with neurogenic bladder secondary to spinal cord injury. J Spinal Cord Med 2004; 27: 35–40PubMed
77.
Zurück zum Zitat Linsenmeyer TA, Harrison B, Oakley A, et al. Evaluation of cranberry supplement for reduction of urinary tract infections in individuals with neurogenic bladders secondary to spinal cord injury. a prospective, double-blinded, placebo-controlled, crossover study. J Spinal Cord Med 2004; 27: 29–34 Linsenmeyer TA, Harrison B, Oakley A, et al. Evaluation of cranberry supplement for reduction of urinary tract infections in individuals with neurogenic bladders secondary to spinal cord injury. a prospective, double-blinded, placebo-controlled, crossover study. J Spinal Cord Med 2004; 27: 29–34
78.
Zurück zum Zitat Lee BB, Haran MJ, Hunt LM, et al. Spinal-injured neuropathic bladder antisepsis (SINBA) trial. Spinal Cord 2007; 45: 542–50PubMedCrossRef Lee BB, Haran MJ, Hunt LM, et al. Spinal-injured neuropathic bladder antisepsis (SINBA) trial. Spinal Cord 2007; 45: 542–50PubMedCrossRef
79.
Zurück zum Zitat Hess MJ, Hess PE, Sullivan MR, et al. Evaluation of cranberry tablets for the prevention of urinary tract infections in spinal cord injured patients with neurogenic bladder. Spinal Cord 2008; 46: 622–6PubMedCrossRef Hess MJ, Hess PE, Sullivan MR, et al. Evaluation of cranberry tablets for the prevention of urinary tract infections in spinal cord injured patients with neurogenic bladder. Spinal Cord 2008; 46: 622–6PubMedCrossRef
80.
Zurück zum Zitat Avorn J, Monane M, Gurwitz JA, et al. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA 1994; 271: 751–4PubMedCrossRef Avorn J, Monane M, Gurwitz JA, et al. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA 1994; 271: 751–4PubMedCrossRef
81.
Zurück zum Zitat McMurdo MET, Bissett LY, Price RJG, et al. Does ingestion of cranberry juice reduce symptomatic urinary tract infections in older people in hospital? A double-blind, placebo-controlled trial. Age Ageing 2005; 34: 256–61PubMedCrossRef McMurdo MET, Bissett LY, Price RJG, et al. Does ingestion of cranberry juice reduce symptomatic urinary tract infections in older people in hospital? A double-blind, placebo-controlled trial. Age Ageing 2005; 34: 256–61PubMedCrossRef
82.
Zurück zum Zitat Wing DA, Rumney PJ, Preslicka CW, et al. Daily cranberry juice for the prevention of asymptomatic bacteriuria in pregnancy: a randomized, controlled pilot study. J Urol 2008; 180: 1367–72PubMedCrossRef Wing DA, Rumney PJ, Preslicka CW, et al. Daily cranberry juice for the prevention of asymptomatic bacteriuria in pregnancy: a randomized, controlled pilot study. J Urol 2008; 180: 1367–72PubMedCrossRef
83.
Zurück zum Zitat Foda MMR, Middlebrook PF, Gatfield CT, et al. Efficacy of cranberry in prevention of urinary tract infection in a susceptible pediatric population. Can J Urol 1995; 2: 98–102PubMed Foda MMR, Middlebrook PF, Gatfield CT, et al. Efficacy of cranberry in prevention of urinary tract infection in a susceptible pediatric population. Can J Urol 1995; 2: 98–102PubMed
84.
Zurück zum Zitat Schlager TA, Anderson S, Trudell J, et al. Effect of cranberry juice on bacteriuria in children with neurogenic bladder receiving intermittent catheterization. J Pediatr 1999; 135: 698–702PubMedCrossRef Schlager TA, Anderson S, Trudell J, et al. Effect of cranberry juice on bacteriuria in children with neurogenic bladder receiving intermittent catheterization. J Pediatr 1999; 135: 698–702PubMedCrossRef
85.
Zurück zum Zitat Avorn J, Monane M, Gurwitz J, et al. Reduction of bacteriuria and pyuria with cranberry beverage: a randomized trial [abstract no. A51]. J Am Geriatr Soc 1993; 41 (Suppl.): SA13 Avorn J, Monane M, Gurwitz J, et al. Reduction of bacteriuria and pyuria with cranberry beverage: a randomized trial [abstract no. A51]. J Am Geriatr Soc 1993; 41 (Suppl.): SA13
86.
Zurück zum Zitat Jepson RG, Craig J. A systematic review of the evidence for cranberries and blueberries in UTI prevention. Mol Nutr Food Res 2007; 51: 738–45PubMedCrossRef Jepson RG, Craig J. A systematic review of the evidence for cranberries and blueberries in UTI prevention. Mol Nutr Food Res 2007; 51: 738–45PubMedCrossRef
87.
Zurück zum Zitat Jepson RG, Craig J. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2008; (1): CD001321 Jepson RG, Craig J. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2008; (1): CD001321
88.
Zurück zum Zitat Kontiokari T, Salo J, Eerola E, et al. Cranberry juice and bacterial colonization in children: a placebo-controlled randomized trial. Clin Nutr 2005; 24: 1065–72PubMedCrossRef Kontiokari T, Salo J, Eerola E, et al. Cranberry juice and bacterial colonization in children: a placebo-controlled randomized trial. Clin Nutr 2005; 24: 1065–72PubMedCrossRef
89.
Zurück zum Zitat Elliott SP, Villar R, Duncan B. Bacteriuria management and urological evaluation of patients with spina bifida and neurogenic bladder: a multicenter survey. J Urol 2005; 173: 217–20PubMedCrossRef Elliott SP, Villar R, Duncan B. Bacteriuria management and urological evaluation of patients with spina bifida and neurogenic bladder: a multicenter survey. J Urol 2005; 173: 217–20PubMedCrossRef
90.
Zurück zum Zitat Super EA, Kemper KJ, Woods C, et al. Cranberry use among pediatric nephrology patients. Ambul Pediatr 2005; 5: 249–52PubMedCrossRef Super EA, Kemper KJ, Woods C, et al. Cranberry use among pediatric nephrology patients. Ambul Pediatr 2005; 5: 249–52PubMedCrossRef
91.
Zurück zum Zitat Hutchinson J. Do cranberries help prevent urinary tract infections? Nurs Times 2005; 101: 38–40PubMed Hutchinson J. Do cranberries help prevent urinary tract infections? Nurs Times 2005; 101: 38–40PubMed
92.
Zurück zum Zitat Jepson RG, Mihaljevic L, Craig J. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev2004;(2):CD001321 Jepson RG, Mihaljevic L, Craig J. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev2004;(2):CD001321
93.
Zurück zum Zitat Crews Jr WD, Harrison DW, Griffin ML, et al. A double-blind, placebo-controlled, randomized trial of the neu-ropsychologic efficacy of cranberry juice in a sample of cognitively intact older adults: pilot study finding. J Altern Compl Med 2005; 11: 305–9CrossRef Crews Jr WD, Harrison DW, Griffin ML, et al. A double-blind, placebo-controlled, randomized trial of the neu-ropsychologic efficacy of cranberry juice in a sample of cognitively intact older adults: pilot study finding. J Altern Compl Med 2005; 11: 305–9CrossRef
95.
Zurück zum Zitat Kessler T, Jansen B, Hesse A. Effect of black currant-,cranberry-, and plum juice consumption on risk factors associated with kidney stone formation. Eur J Clin Nutr 2002; 56: 1020–3PubMedCrossRef Kessler T, Jansen B, Hesse A. Effect of black currant-,cranberry-, and plum juice consumption on risk factors associated with kidney stone formation. Eur J Clin Nutr 2002; 56: 1020–3PubMedCrossRef
96.
Zurück zum Zitat McHarg T, Rodgers A, Charlton K. Influence of cranberry juice on the urinary risk factors for calcium oxalate kidney stone formation. BJU Int 2003; 92: 765–8PubMedCrossRef McHarg T, Rodgers A, Charlton K. Influence of cranberry juice on the urinary risk factors for calcium oxalate kidney stone formation. BJU Int 2003; 92: 765–8PubMedCrossRef
97.
Zurück zum Zitat Gettman MT, Ogan K, Brinkley LJ, et al. Effect of cranberry juice consumption on urinary stone risk factors. J Urol 2005; 174: 590–4PubMedCrossRef Gettman MT, Ogan K, Brinkley LJ, et al. Effect of cranberry juice consumption on urinary stone risk factors. J Urol 2005; 174: 590–4PubMedCrossRef
98.
Zurück zum Zitat Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001; 57: 26–9PubMedCrossRef Terris MK, Issa MM, Tacker JR. Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001; 57: 26–9PubMedCrossRef
99.
Zurück zum Zitat Ross SM. Clinical applications of cranberry in urinary tract infections. Holistic Nurs Prac 2006; 20: 213–4 Ross SM. Clinical applications of cranberry in urinary tract infections. Holistic Nurs Prac 2006; 20: 213–4
100.
Zurück zum Zitat Dugoua J-J, Seely D, Perri D, et al. Safety and efficacy of cranberry (Vaccinium macrocarpon) during pregnancy and lactation. Can J Clin Pharmacol 2008; 15: e80–6PubMed Dugoua J-J, Seely D, Perri D, et al. Safety and efficacy of cranberry (Vaccinium macrocarpon) during pregnancy and lactation. Can J Clin Pharmacol 2008; 15: e80–6PubMed
101.
Zurück zum Zitat Nordeng H, Havnen GC. Use of herbal drugs in pregnancy: a survey among 400 Norwegian women. Pharmacoepidemiol Drug Saf 2004; 13: 371–80PubMedCrossRef Nordeng H, Havnen GC. Use of herbal drugs in pregnancy: a survey among 400 Norwegian women. Pharmacoepidemiol Drug Saf 2004; 13: 371–80PubMedCrossRef
102.
Zurück zum Zitat Hodek P, Trefil P, Stiborova M. Flavonoids-potent and versatile biologically active compounds interacting with cytochrome P450. Chem Biol Interact 2002; 139: 1–21PubMedCrossRef Hodek P, Trefil P, Stiborova M. Flavonoids-potent and versatile biologically active compounds interacting with cytochrome P450. Chem Biol Interact 2002; 139: 1–21PubMedCrossRef
103.
Zurück zum Zitat Uesawa Y, Mohri K. Effects of cranberry juice on nifedi-pine pharmacokinetics in rats. J Pharm Pharmacol 2006; 58: 1067–72PubMedCrossRef Uesawa Y, Mohri K. Effects of cranberry juice on nifedi-pine pharmacokinetics in rats. J Pharm Pharmacol 2006; 58: 1067–72PubMedCrossRef
104.
Zurück zum Zitat Grenier J, Fradette C, Morelli G, et al. Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. Clin Pharmacol Ther 2006; 79: 255–62PubMedCrossRef Grenier J, Fradette C, Morelli G, et al. Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. Clin Pharmacol Ther 2006; 79: 255–62PubMedCrossRef
105.
Zurück zum Zitat Greenblatt DJ, von Moltke LL, Perloff ES, et al. Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies. Clin Pharmacol Ther 2006; 79: 125–33PubMedCrossRef Greenblatt DJ, von Moltke LL, Perloff ES, et al. Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies. Clin Pharmacol Ther 2006; 79: 125–33PubMedCrossRef
106.
Zurück zum Zitat Lilja JJ, Backman JT, Neuvonen PJ. Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam — probes of CYP2C9, CYP1A2, and CYP3A 4. Clin Pharmacol Ther 2007; 81: 833–9PubMedCrossRef Lilja JJ, Backman JT, Neuvonen PJ. Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam — probes of CYP2C9, CYP1A2, and CYP3A 4. Clin Pharmacol Ther 2007; 81: 833–9PubMedCrossRef
107.
Zurück zum Zitat Suvarna R, Pirmohamed M, Henderson L. Possible interaction between warfarin and cranberry juice. BMJ 2003; 327: 1454PubMedCrossRef Suvarna R, Pirmohamed M, Henderson L. Possible interaction between warfarin and cranberry juice. BMJ 2003; 327: 1454PubMedCrossRef
108.
Zurück zum Zitat Grant P. Warfarin and cranberry juice: an interaction? J Heart Valve Dis 2004; 13: 25–6PubMed Grant P. Warfarin and cranberry juice: an interaction? J Heart Valve Dis 2004; 13: 25–6PubMed
109.
Zurück zum Zitat Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. Am J Ther 2005; 13: 283–4CrossRef Rindone JP, Murphy TW. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding. Am J Ther 2005; 13: 283–4CrossRef
110.
Zurück zum Zitat Paeng CH, Sprague M, Jackevicius CA. Interaction between warfarin and cranberry juice. Clin Ther 2007; 29: 1730–5PubMedCrossRef Paeng CH, Sprague M, Jackevicius CA. Interaction between warfarin and cranberry juice. Clin Ther 2007; 29: 1730–5PubMedCrossRef
111.
Zurück zum Zitat Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006; 26: 1314–9PubMedCrossRef Aston JL, Lodolce AE, Shapiro NL. Interaction between warfarin and cranberry juice. Pharmacotherapy 2006; 26: 1314–9PubMedCrossRef
112.
Zurück zum Zitat Anonymous. Possible interaction between warfarin and cranberry juice. Curr Probl Pharmacovigil 2003; 29: 8 Anonymous. Possible interaction between warfarin and cranberry juice. Curr Probl Pharmacovigil 2003; 29: 8
113.
Zurück zum Zitat Li Z, Seeram NP, Carpenter CL, et al. Cranberry does not affect prothrombin time in male subjects on warfarin. J Am Diet Assoc 2006; 106: 2057–61PubMedCrossRef Li Z, Seeram NP, Carpenter CL, et al. Cranberry does not affect prothrombin time in male subjects on warfarin. J Am Diet Assoc 2006; 106: 2057–61PubMedCrossRef
114.
Zurück zum Zitat Abdul MM, Jiang X, Williams KM, et al. Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br J Pharmacol 2008; 154: 1691–700CrossRef Abdul MM, Jiang X, Williams KM, et al. Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br J Pharmacol 2008; 154: 1691–700CrossRef
115.
Zurück zum Zitat Lynch DM. Cranberry for prevention of urinary tract infections. Am Fam Phys 2004; 70: 2175–7 Lynch DM. Cranberry for prevention of urinary tract infections. Am Fam Phys 2004; 70: 2175–7
116.
Zurück zum Zitat Bononi M, Tateo F. Stabilization of cranberry anthocyanins in nutraceutical capsules. Int J Food Sci Nutr 2007; 58: 142–9PubMedCrossRef Bononi M, Tateo F. Stabilization of cranberry anthocyanins in nutraceutical capsules. Int J Food Sci Nutr 2007; 58: 142–9PubMedCrossRef
117.
Zurück zum Zitat Beerepoot MA, Stobberingh EE, Geerlings SE. A study of non-antibiotic versus antibiotic prophylaxis for recurrent urinary-tract infections in women (the NAPRUTI study). Ned Tijdschr Geneeskd 2006; 150: 574–5PubMed Beerepoot MA, Stobberingh EE, Geerlings SE. A study of non-antibiotic versus antibiotic prophylaxis for recurrent urinary-tract infections in women (the NAPRUTI study). Ned Tijdschr Geneeskd 2006; 150: 574–5PubMed
118.
Zurück zum Zitat Stothers L. Effects of cranberry-containing products in women with recurrent urinary tract infections (UTIs) [ClinicalTrials.gov identifier NCT0010061]. US National Institutes of Health, ClinicalTrials.gov [online]. Available from URL: http://www.clincaltrials.gov [Accessed 2007 Mar 26] Stothers L. Effects of cranberry-containing products in women with recurrent urinary tract infections (UTIs) [ClinicalTrials.gov identifier NCT0010061]. US National Institutes of Health, ClinicalTrials.gov [online]. Available from URL: http://​www.​clincaltrials.​gov [Accessed 2007 Mar 26]
119.
Zurück zum Zitat McMurdo MET, Argo I, Phillips G, et al. Cranberry or trimethoprim for the prevention of recurrent urinary tract infections? A randomized controlled trial in older women. J Antimicrob Chemother 2009; 63: 389–95PubMedCrossRef McMurdo MET, Argo I, Phillips G, et al. Cranberry or trimethoprim for the prevention of recurrent urinary tract infections? A randomized controlled trial in older women. J Antimicrob Chemother 2009; 63: 389–95PubMedCrossRef
Metadaten
Titel
Cranberry and Urinary Tract Infections
verfasst von
Dr David R.P. Guay
Publikationsdatum
01.05.2009
Verlag
Springer International Publishing
Erschienen in
Drugs / Ausgabe 7/2009
Print ISSN: 0012-6667
Elektronische ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-200969070-00002

Weitere Artikel der Ausgabe 7/2009

Drugs 7/2009 Zur Ausgabe

Adis Drug Evaluation

Sugammadex

Adis Drug Evaluation

Exemestane

Review Article

Ceftaroline

Adis Drug Evaluation

Bortezomib